VVUS:Vivus Inc - Stock Price Quote and Dividend Data
VVUS STOCK PRICE LATEST CLOSE
$0.47
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Vivus Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
Vivus Inc Stock Price Information
52-Week Low/High Stock Price$0.44 - $4.75
Percent Held by Institutions15.10%
Revenue$92,876,000
Net Income$-33,980,000
Cash Flow$114,000
EPS-0.49%
Market Cap$8,335,422
PE Ratio to Industry39%
Debt-Equity Ratio999,999.02%
Debt-Equity to Industry1.16%
Total Return Last 12 Months-86.24%
Total Return Last 3 Years-96.33%
Total Return Last 5 Years-97.89%
Latest Trade DateJul. 16, 2020
Vivus Inc Annual Stock Dividends
No Data available for Payment History.
Vivus Inc Dividend Payment History
| No dividends retrieved for VVUS |
Vivus Inc Other Dividend Details
VIVUS is a pharmaceutical company with three approved therapies and one product candidate in active clinical development. PANCREAZE® (pancrelipase) is indicated for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Qsymia® (phentermine and topiramate extended release) is approved by FDA for chronic weight management. STENDRA® (avanafil) is approved by FDA for erectile dysfunction (ED) and by the European Commission under the trade name SPEDRA, for the treatment of ED in the European Union. VI-0106 (tacrolimus) is in active clinical development and is being studied in patients with pulmonary arterial hypertension.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Jul. 17, 2020CLOSE PRICE DECREASE: Vivus Inc (NASDAQ: VVUS) on 07-17-2020 decreased close price > 10% from $0.52 to $0.47
Jul. 16, 2020CLOSE PRICE DECREASE: Vivus Inc (NASDAQ: VVUS) on 07-16-2020 decreased close price > 10% from $0.61 to $0.52
Jul. 15, 2020CLOSE PRICE INCREASE: Vivus Inc (NASDAQ: VVUS) on 07-15-2020 increased close price > 10% from $0.46 to $0.61
Jul. 14, 2020CLOSE PRICE DECREASE: Vivus Inc (NASDAQ: VVUS) on 07-14-2020 decreased close price > 10% from $0.53 to $0.46
Jul. 10, 2020CLOSE PRICE DECREASE: Vivus Inc (NASDAQ: VVUS) on 07-10-2020 decreased close price > 10% from $0.68 to $0.57
Jul. 09, 2020CLOSE PRICE DECREASE: Vivus Inc (NASDAQ: VVUS) on 07-09-2020 decreased close price > 10% from $0.81 to $0.68
Jun. 23, 2020CLOSE PRICE DECREASE: Vivus Inc (NASDAQ: VVUS) on 06-23-2020 decreased close price > 10% from $1.04 to $0.92
Jun. 20, 2020CLOSE PRICE DECREASE: Vivus Inc (NASDAQ: VVUS) on 06-20-2020 decreased close price > 10% from $1.16 to $1.04
Jun. 10, 2020CLOSE PRICE DECREASE: Vivus Inc (NASDAQ: VVUS) on 06-10-2020 decreased close price > 10% from $1.47 to $1.28
Jun. 09, 2020CLOSE PRICE INCREASE: Vivus Inc (NASDAQ: VVUS) on 06-09-2020 increased close price > 10% from $1.11 to $1.47
Apr. 10, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-10-2025 decreased stock price > 10% from $0.65 to $0.52
Apr. 10, 2025SXTP STOCK PRICE DECREASE: 60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $2.87 to $2.50
Apr. 10, 2025BMYMP STOCK PRICE DECREASE: $2 Cv. Pfd./Bristol Myers Squibb Co. on 04-10-2025 decreased stock price > 10% from $1,003.20 to $901.50
Apr. 10, 2025PBMWW STOCK PRICE DECREASE: Wt Exp/Psyence Biomedical Ltd on 04-10-2025 decreased stock price > 10% from $0.03 to $0.02
Apr. 10, 2025UPC STOCK PRICE DECREASE: Ord Shs (New)/Universe Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $3.95 to $3.28
Apr. 10, 2025SXTPW STOCK PRICE DECREASE: Wt Exp/60 Degrees Pharmaceuticals Inc on 04-10-2025 decreased stock price > 10% from $0.07 to $0.04
Apr. 10, 2025RGBP STOCK PRICE DECREASE: Regen BioPharma Inc on 04-10-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 10, 2025DRRX STOCK PRICE DECREASE: Durect Corp on 04-10-2025 decreased stock price > 10% from $0.80 to $0.71
Apr. 10, 2025IXHL STOCK PRICE DECREASE: Incannex Healthcare Inc on 04-10-2025 decreased stock price > 10% from $0.84 to $0.68
Apr. 10, 2025CLABF STOCK PRICE DECREASE: Com No Par/Core One Labs Inc on 04-10-2025 decreased stock price > 10% from $0.09 to $0.04
